Source comparison
Tesamorelin Ipamorelin Blend Doses: Comparison Table
1mL 100mcg + 100mcg 0.02mL 50 Exceeds 28-day window. Peptide degrades before depletion 2mL 200mcg + 200mcg 0.08mL 25 Optimal. Finishes within stability window 250mcg + 250mcg 0.10mL 20 500mcg + 500mcg 0.20mL 10 Finishes quickly. Consider larger vials for exten
This comparison does not assign a generated winner or score.
- 1mL
- 100mcg + 100mcg
- 0.02mL
- 50
- Exceeds 28-day window. Peptide degrades before depletion
- 2mL
- 200mcg + 200mcg
- 0.08mL
- 25
- Optimal. Finishes within stability window
- 250mcg + 250mcg
- 0.10mL
- 20
- 500mcg + 500mcg
- 0.20mL
- 10
- Finishes quickly. Consider larger vials for extended protocols
- 3mL
- 300mcg + 300mcg
- 0.18mL
- 16
- Acceptable but larger syringe volumes increase waste
- Professional Assessment
- 2mL reconstitution with 200–300mcg daily dosing per peptide aligns vial depletion with the 28-day refrigerated stability limit. Maximising peptide utilisation without degradation waste.